Bipolar Disorder Clinical Trial
Official title:
Family Focused Therapy (FFT) for Adolescents at Familial Risk for Bipolar
NCT number | NCT02355366 |
Other study ID # | 404-2014 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2015 |
Est. completion date | November 26, 2018 |
Verified date | January 2019 |
Source | Sunnybrook Health Sciences Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The present study aims to examine the effects of a 4 month, family focused therapy (FFT) intervention on the 1 year course of mood symptoms in offspring of parents with bipolar disorder (BD). The study will also examine the level of expressed emotion among families and how this impacts on FFT treatment outcomes. This study seeks to replicate a previous study by Miklowitz, Schneck, Singh, Taylor, George and colleagues (2013), which demonstrated the efficacy of FFT among BD offspring. Importantly, the present study will introduce biological measures that predict and reflect improvement in symptoms and expressed emotion. These markers reflect stress-related biological systems and include saliva samples to ascertain cortisol, interleukin-6 (IL-6) and salivary alpha amylase (sAA).
Status | Terminated |
Enrollment | 2 |
Est. completion date | November 26, 2018 |
Est. primary completion date | November 26, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 13 Years to 19 Years |
Eligibility |
Inclusion Criteria: 1. English-speaking males and females of any race/ethnicity 2. 13-19 years of age 3. Have at least 1 biological parent who meets diagnostic criteria for bipolar disorder (BD) type I or II, based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) 4. Adolescent is experiencing current, significant mood symptoms indicated by a psychiatric status rating (PSR) score of 3 5. At least 1 parent/primary caregiver is available to attend sessions. All participants will complete rigorous diagnostic interviews to ensure that they meet these requirements. Exclusion Criteria: 1. Unable to provide informed consent (e.g., severe psychosis, developmental delay) 2. Have met the DSM-IV criteria (based on the Schedule for Affective Disorders and Schizophrenia for School Age Children, Present and Life Version - K-SADS-PL), for substance dependence in the past 3 months (excluding nicotine dependence) 3. Are victims of current sexual or physical abuse by parents or live among domestic violence 4. For offspring, already meet criteria for bipolar disorder (BD) type I or II. |
Country | Name | City | State |
---|---|---|---|
Canada | Sunnybrook Health Sciences Centre | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
Sunnybrook Health Sciences Centre |
Canada,
Miklowitz DJ, Schneck CD, Singh MK, Taylor DO, George EL, Cosgrove VE, Howe ME, Dickinson LM, Garber J, Chang KD. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry. 2013 Feb;52(2):121-31. doi: 10.1016/j.jaac.2012.10.007. Epub 2013 Jan 2. — View Citation
Miklowitz DJ. Family-focused treatment for children and adolescents with bipolar disorder. Isr J Psychiatry Relat Sci. 2012;49(2):95-101. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | KSADS Mania Rating Scale (KMRS) | Measures symptom severity. | Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months) | |
Primary | KSADS Depression Section (KDRS) | Measures symptom severity. | Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months) | |
Primary | Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE) | Used to track symptom severity, treatment (both psychosocial and psychotropic), self-injurious/suicidal behavior and psychosocial functioning over time. | Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months) | |
Primary | The Family Environment Scale (FES) | Examines each family member's perceptions of the family in three ways—as it is (real), as it would be in a perfect situation (ideal) and as it will probably be in new situations (expected). | Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months) | |
Primary | Family Adaptability & Cohesion & Adaptability Scale (FACES) | Evaluate the adaptability and cohesion dimensions in family interactions. | Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months) | |
Primary | Conflict Behaviour Questionnaire (CBQ) | Measures conflict and negative communication between parents and adolescents. | Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months) | |
Primary | Issues Checklist | Measures potential areas of conflict between parents and adolescents. | Change from baseline to endpoint (assessed at 0, 4 and 12 months) | |
Primary | Cortisol | Stress-related biomarker obtained through saliva samples. | Change from baseline to endpoint (assessed at 0, 4, and 12 months) | |
Primary | Interleukin 6 (IL-6) | Stress-related biomarker obtained through saliva samples. | Change from baseline to endpoint (assessed at weeks 0, 4, and 12 months) | |
Primary | Alpha Amylase | Stress-related biomarker obtained through saliva samples. | Change from baseline to endpoint (assessed at 0, 4, and 12 months) | |
Primary | Five Minute Speech Sample | Assesses level of expressed emotion (EE) within the parental household. | Change from baseline to endpoint (assessed at 0, 4, and 12 months) | |
Primary | Emotional Response to Conflict Scale (ERCS) | Assesses individuals' emotional responses to a brief, laboratory based, conflict negotiation task. | Change from baseline to endpoint (assessed at 0, 4 and 12 months) | |
Secondary | Children Global Assessment Scale | Quantifies overall level of functioning for a child or adolescent during a specified time period. | Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months) | |
Secondary | Anthromorphic Data | Measures height, weight, body mass index, & blood pressure. | Change from baseline to endpoint (Assessed at weeks 0 and 12 months) | |
Secondary | Working Alliance Inventory Short-Revised (WAI-SR) | Measures therapeutic alliance. | Change from baseline to endpoint. For FFT Group: Assessed after therapy sessions 1, 4, 8 & 12. For Education Control Group: Assessed after therapy sessions 1 & 2. | |
Secondary | General Information Sheet | Demographics | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|